Muscle cell-derived factors inhibit inflammatory stimuli-induced damage in hMSC-derived chondrocytes  by Rainbow, R.S. et al.
Osteoarthritis and Cartilage 21 (2013) 990e998Muscle cell-derived factors inhibit inﬂammatory stimuli-induced
damage in hMSC-derived chondrocytes
R.S. Rainbow y, H. Kwon yz, A.T. Foote y, R.C. Preda x, D.L. Kaplan x, L. Zeng yzk*
yDepartment of Anatomy and Cellular Biology, Tufts University School of Medicine, 136 Harrison Avenue, Boston, MA 02111, USA
z Program in Cellular, Molecular and Developmental Biology, Sackler School of Graduate Biomedical Sciences, Tufts University, 136 Harrison Avenue,
Boston, MA 02111, USA
xDepartment of Biomedical Engineering, Tufts University, 4 Colby Street, Medford, MA 02155, USA
kDepartment of Orthopaedic Surgery, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USAa r t i c l e i n f o
Article history:
Received 5 October 2012
Accepted 14 April 2013
Keywords:
Cartilage tissue engineering
Osteoarthritis
Pro-inﬂammatory
Cytokines
Myokines
Stem cells* Address correspondence and reprint requests
Anatomy and Cellular Biology, Tufts University Scho
Avenue, Boston, MA 02111, USA. Tel: 1-617-636-2107
E-mail address: li.zeng@tufts.edu (L. Zeng).
1063-4584/$ e see front matter  2013 Osteoarthriti
http://dx.doi.org/10.1016/j.joca.2013.04.011s u m m a r y
Objective: Pro-inﬂammatory cytokines play an important role in inducing cartilage degradation during
osteoarthritis pathogenesis. Muscle is a tissue that lies near cartilage in situ. However, muscle’s non-
loading biochemical effect on cartilage has been largely unexplored. Here, we tested the hypothesis
that muscle cells can regulate the response to pro-inﬂammatory cytokine-mediated damage in chon-
drocytes derived from human bone marrow-derived mesenchymal stem cells (hMSCs).
Method: hMSCs were allowed to undergo chondrogenic differentiation in porous silk scaffolds in the
typical chondrogenic medium for 12 days. For the next 9 days, the cells were cultured in chondrogenic
medium containing 50% conditioned medium derived from C2C12 muscle cells or ﬁbroblast control cells,
and were subject to treatments of pro-inﬂammatory cytokines IL-1b or TNFa.
Results: Both IL-1b and TNFa-induced strong expression of multiple MMPs and hypertrophic markers
Runx2 and type X collagen. Strikingly, culturing hMSC-derived chondrocytes in C2C12 muscle cell-
conditioned medium strongly inhibited the expression of all these genes, a result further conﬁrmed
by GAG content and histological evaluation of matrix protein. To determine whether these effects were
due to altered chondrocyte growth and survival, we assayed the expression of cell proliferation marker
Ki67, cell cycle arrest markers p21 and p53, and apoptosis marker caspase 3. Muscle cell-conditioned
medium promoted proliferation and inhibited apoptosis, thereby suggesting a possible decrease in the
cellular aging and death that typically accompanies cartilage inﬂammation.
Conclusion: Our ﬁndings suggest the role of muscle in cartilage homeostasis and provide insight into
designing strategies for promoting resistance to pro-inﬂammatory cytokines in hMSC-derived
chondrocytes.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Articular cartilage serves a load-bearing role in diarthrodial
joints1,2. However, degenerative erosion of this tissue can lead to
osteoarthritis (OA) which is estimated to affect 71 million North
Americans by the year 20303. Due to the narrow reparative po-
tential of cartilage, along with its avascular and aneural nature4,
current treatments are mainly restricted to alleviating symptoms
and pain5. Cartilage tissue engineering has emerged as an attractive
therapeutic option for restoring and regenerating cartilage in situ.to: L. Zeng. Department of
ol of Medicine, 136 Harrison
; Fax: 1-617-636-3676.
s Research Society International. PSuch strategies rely on the combination of repair cells with the
appropriate three-dimensional (3D) biomaterial scaffolding and
biochemical cues necessary to create a regenerative microenvi-
ronment. Engineered constructs can then be implanted at the site
of injury to facilitate healing and restoration of tissue function.
For adequate healing and regeneration, engineered cartilage re-
quires appropriate coupling of progenitor repair cells with biocom-
patible scaffolding that facilitates the generation of a tissue construct
similar to native cartilage. With respect to progenitor repair cells,
matrix-secreting primary chondrocytes are limited in quantity and
capacity for expansion, and are susceptible to de-differentiation
in vitro4,6. In comparison, human bone marrow-derived mesen-
chymal stem cells (hMSCs) have emerged as an attractive cell source
for cartilage tissue engineering4,6. These multipotent cells can be
obtained in relatively large amounts, rapidly expanded ex vivo, andublished by Elsevier Ltd. All rights reserved.
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scaffolding, multiple materials have been explored for engineering
cartilage tissue. Among them, silk, derived from the Bombyx mori
(silkworm), stands out as a biomaterial whose biocompatibility, slow
degradation, and robust mechanical properties make it suitable for
cartilage tissue engineering8e11.
The hostile pathological environment in the arthritic joint im-
poses a major challenge on cartilage tissue engineering. For suc-
cessful cartilage repair, the engineered tissue construct must also
be able to maintain its stability in the inﬂammatory microenvi-
ronment in vivo during OA pathogenesis12,13. In the joint, pro-
inﬂammatory cytokines, most notably IL-1b and TNFa, cause
cartilage damage in OA by stimulating the expression of a number
of proteolytic enzymes, including matrix metalloproteinases
(MMPs) and aggrecanases5,14e16. Additionally, to further drive the
degradation cascade, IL-1b and TNFa also promote chondrocyte
hypertrophy, cellular senescence, and cell death, thereby reducing
the proliferation and viability potential for chondrocytes5,17,18.
Muscle lies in close proximity to cartilage during development19
and throughout life. This tissue provides cartilage with a biome-
chanical stimulation that promotes nutrient distribution and
maintains homeostasis20. For example, age-associated muscle loss
is linked to the progression of OA in the elderly21 and reduced
muscle strength has been shown to be a risk factor for knee OA22. As
a result, muscle strengthening has been explored as an intervention
to prevent or delay the onset of OA23. Furthermore, muscle paral-
ysis, which leads to muscle atrophy, induces joint abnormality and
cartilage degradation24e26. On the other hand, bonemorphogenetic
protein 2 (BMP-2)-expressing muscle tissue was found to serve as a
bridge in enhancing and accelerating femur fracture healing in a rat
model27. While these studies have demonstrated the signiﬁcance of
muscle tissue on skeletal development, it is unclear whether this
regulation involves merely biomechanical stimuli, biochemical
mediators, or both28,29.
Recently, our group investigated the non-loading biochemical
effect of muscle cells on cartilage gene expression. Our results
showed that a rat chondrocyte cell line co-cultured with muscle
cells or cultured in muscle cell-conditioned medium as monolayers
had signiﬁcantly higher expression levels of cartilage matrix pro-
teins in the presence of IL-1b and TNFa30,31. However, for the pur-
pose of tissue engineering, it is critical to evaluate the effect of
muscle cell-derived factors on primary cells in a 3D microenvi-
ronment under such inﬂammatory stimuli.
In this study, we subjected hMSCs-derived differentiating
chondrocytes grown in 3D silk scaffolds to C2C12 muscle cell-
conditioned media as well as pro-inﬂammatory cytokines IL-1b
and TNFa. Administration of IL-1b and TNFa strongly induced the
gene expression of matrix degrading enzymes (MMPs) and hyper-
trophic markers such as Runx2 and type X collagen (Col X) in
hMSC-derived chondrocytes. In contrast, culturing in conditioned
medium derived from C2C12 muscle cells resulted in strong inhi-
bition of the expression of these genes, a result further conﬁrmed
by quantiﬁcation of proteoglycan content and histological assess-
ment. To determine whether muscle cell-derived factors altered
chondrocyte growth and survival, we assayed the expression of cell
proliferation and cell cycle arrest markers as well as apoptosis
markers. We found that culturing in muscle cell-conditioned me-
dium promoted chondrocyte proliferation and inhibited cell death
under inﬂammatory stimuli. Together, our ﬁndings demonstrate
that muscle cell-derived factors, or myokines, provide enhanced
resistance to pro-inﬂammatory cytokine-mediated cartilage
degradation, hypertrophy, and cell growth arrest in hMSC-derived
chondrocytes and suggest that such factors may be utilized to
improve the stability of bioengineered cartilage in the hostile
microenvironment of arthritic joints.Methods
Biomaterial scaffolds
Silk ﬁbroin scaffolds were fabricated as previously described8.
Brieﬂy, B. mori cocoons were boiled in 0.02 M Na2CO3 to extract
sericin proteins. Silk ﬁbroin solution was then lyophilized and
resuspended in 1,1,1,3,3,3-hexaﬂuoro-2-propanol (HFIP). NaCl
particles (size: 106e212 mm) were added to 12% silk-HFIP
solution (w/v) to generate porous scaffolds with a pore size of
106-212 mm. Scaffolds were then punched into 5 mm  3 mm
(diameter  height) disks for our experiments. Scaffolds of the
same dimensions, made of D,D-L,L polylactic acid (PLA) and bovine
type I and type III collagen, were obtained from BD Biosciences
(Franklin Lakes, NJ).Cell culture
hMSCs were purchased from Lonza Walkersville, Inc
(Walkersville, MD). The lot numbers purchased were 1-OF3825
(donor #1), 8F3520 (donor #2), and 3F4287 (donor #3). Cells were
expanded in Dulbecco’s Modiﬁed Eagle Medium (DMEM) (Gibco,
Grand Island, NY) containing 10% fetal bovine serum (FBS)
(Hyclone, Rockford, IL), 1% antibiotic-antimycotic (Gibco), 0.1 mM
non-essential amino acids (Gibco), and 1 ng/mL basic ﬁbroblast
growth factor (Peprotech, Rocky Hill, NJ). For chondrogenic differ-
entiation, cells were cultured DMEM containing 1% antibiotic-
antimycotic, ITS þ supplement (BD Biosciences), 0.1 mM ascorbic
acid 2-phosphate (Sigma Aldrich, St. Louis MO), 1.25 mg/mL human
serum albumin (Sigma), 107 M dexamethasone (Sigma), and
10 ng/mL transforming growth factor beta 3 (TGF-b3; R&D
Systems).
Murinemyoblast cell line (C2C12) andmurine ﬁbroblast cell line
(NIH3T3) were purchased from ATCC (Rockville, MD). Cell lines
were cultured in DMEM with 10% FBS and 1% antibiotic-
antimycotic. Cells were maintained at a 75e80% conﬂuence for
24 h. Conditioned medium was sterile-ﬁltered using a 0.22-mm
syringe ﬁlter for subsequent use.hMSC seeding and differentiation
Prior to cell seeding, scaffolds were immersed in sterile DMEM.
0.5  106 hMSCs in 15 mL of chondrogenic media were seeded into
scaffolds and allowed to attach for 2 h. hMSC-seeded scaffolds were
then transferred into 1 mL of fresh media in 24-well tissue culture
plates at 37C under static culturing conditions for 2 days before
being placed on an incubated dynamic shaker (5e6 RPM) for
remainder of study.
For the study of hMSC differentiation on different scaffolds,
hMSCs (passage 4) were seeded into PLA, collagen, or silk scaffolds,
and maintained in chondrogenic media for 21 days. For hMSC dif-
ferentiation in the presence of pro-inﬂammatory cytokines, hMSCs
(passage 5) were differentiated in silk scaffolds for 12 days using
chondrogenic media. At this time, scaffolds were divided into six
groups [Fig. 1(A)] and cultured for an additional 9 days in: 1:1
chondrogenic media and C2C12 conditioned media, 5 ng/mL IL-1b
in a 1:1 mixture of chondrogenic media and C2C12 conditioned
media, and 5 ng/mL TNFa in a 1:1 mixture of chondrogenic media
and C2C12 conditioned media. A control group of scaffolds were
cultured with NIH3T3, rather than C2C12, conditioned media. In all
21-day studies, media was changed every 3 days. Unless stated
otherwise, data shown represents a sample size of n  3 inde-
pendent samples (cell-seeded scaffolds) from one experiment us-
ing one donor.
Fig. 1. Study design and mRNA expression of chondrogenic genes. hMSCs were differentiated for 21 days into chondrocytes using chondrogenic media, with treatment of pro-
inﬂammatory cytokines and muscle cell- or non-muscle control cell-conditioned media after Day 12 (A). Relative expression of markers for cartilage matrix production at Day
12 included transcription factor SOX9 (B), collagen II (Col II) (C), and ACAN (D), as compared to undifferentiated hMSCs at Day 0. Matrix markers at Day 21 included collagen II (E)
and ACAN (F), while hypertrophic markers included Runx2 (G) and collagen X (Col X) (H). Expression was normalized to GAPDH. Data are presented as mean with 95% conﬁdence
intervals (n ¼ 3 independent samples (cell-seeded scaffolds) from one experiment completed using one donor’s cells).
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Total RNA was isolated from scaffolds using the RNeasy Mini kit
(Qiagen; Valencia, CA) as per the manufacturer’s protocol. RNA wasthen transcribed to cDNA using random primers (Invitrogen), M-
MLV reverse transcriptase kit (Invitrogen), and dNTPs (New England
BioLabs; Ipswich, MA) and stored at 20C until RT-PCR analyses.
For RT-PCR, cDNAwasmixed with gene-speciﬁc primers (sequences
R.S. Rainbow et al. / Osteoarthritis and Cartilage 21 (2013) 990e998 993available upon request) and SYBR Green Supermix (Quanta Bio-
sciences, Inc., Gaithersburg, MD), quantiﬁed using BioRad’s iQ5 Real
Time PCR Detection System and optical software (Hercules, CA), and
normalized against gylceraldehyde-3-phosphate-dehydrogenase
(GAPDH). For all analyses, at least three independent samples (cell-
seeded scaffolds) from one experiment were analyzed (n  3).
Histology
Constructs were ﬁxed in formalin, dehydrated in graded ethanol
solutions, clearedwith xylene, embedded in parafﬁn, and sectioned
into 5- or 10-mm thick sections. After deparafﬁnization, sections
were stained with hemotoxilin and 1% eosin (H&E) and toluidine
blue. Diaminobenzidine (DAB) immunocytochemistry was carried
out using the DAB staining kit (Vector Laboratories; Burlingame
CA). Primary antibodies for type II collagen (Abcam; Cambridge,
MA), caspase 3 (Abcam), and Ki67 (Vector Laboratories) were used.
When appropriate, sections were counterstained with methyl
green, prior to imaging and counting.
Sulfated glycosaminoglycans (GAG) and DNA content quantiﬁcation
Constructs were cut into pieces and digested in papain solution
(10 U/mg in PBS containing 5 mM cysteine-HCl and 5 mM EDTA) at
60C overnight, sonicated, and then stored at 20C. Sulfated
glycosaminoglycan (GAG) content was quantiﬁed based on the
absorbance at 525 nm using dimethylmethylene blue (DMMB) dye
and a shark chondroitin sulfate standard32. DNA content was
quantiﬁed using Picogreen (Invitrogen). At least three independent
samples were analyzed for each condition.
Statistical analysis
Each experiment was prepared from a single donor’s cells. Data
was calculated from at least three independent samples (cell-
seeded scaffolds) from one experiment using one donor’s cells and
is reported asmeanwith 95% conﬁdence intervals. Datawas further
analyzed using Prism 4 (Graphpad; La Jolla, CA) and a student’s
t-test or one-way analysis of variance (ANOVA) with Tukey post hoc
assessment. Statistical signiﬁcancewas assignedwhere appropriate
with P < 0.05.
Results
Muscle cell-derived factors inhibit hypertrophy in hMSC-derived
chondrocytes under inﬂammatory stimuli
To assess the effects of muscle cell-derived factors on the
response of hMSC-derived chondrocytes to inﬂammatory cyto-
kines, hMSCs were seeded onto silk scaffolds and allowed to un-
dergo chondrogenic differentiation for 12 days using established
chondrogenic medium11. We chose silk scaffolds for hMSC seeding
based on our comparison study on the chondrogenic potentials of
hMSCs seeded into silk, collagen, or PLA scaffolds, where we found
that hMSCs in silk scaffolds produced the highest content of
GAG and DNA, as well as higher levels of aggrecan (ACAN) mRNA
and lower levels of mRNA for caspase 3 (CASP3) (Fig. S1). For
studying hMSC differentiation in the presence of pro-inﬂammatory
cytokines and muscle-derived factors, we ﬁrst assessed the
expression of cartilage-speciﬁc genes at Day 12 using RT-PCR and
compared to undifferentiated cells at Day 0. While chondrogenesis
is still ongoing at Day 12, a level of chondrogenic differentiation has
been achieved prior to the addition of cytokines and conditioned
media. This ﬁnding is signiﬁed by the induction of SOX 9, a tran-
scription factor that acts as a master regulator in chondrogenicdifferentiation, as well as cartilage matrix genes type II collagen
(Col II) and ACAN [Fig. 1(BeD)].
Over the next 9 days, hMSC-derived chondrocytes were subject
to IL-1b or TNFa treatment. In the presence of pro-inﬂammatory
cytokines, the expression of cartilage matrix genes Col II and
ACAN was signiﬁcantly reduced while expression of hypertrophic
cartilage markers Col X and Runx2 was induced, as compared with
controls [Fig. 1(EeH)]. It was also noted that TNFa had a stronger
effect in inducing chondrocyte hypertrophy than IL-1b [Fig. 1(Ge
H)]. Culturing with C2C12 muscle cell-conditioned medium did not
rescue IL-1b- and TNFa-induced Col II and ACAN reduction
[Fig. 1(EeF)]. Strikingly however, culturing with muscle cell-
conditioned medium led to a signiﬁcant decrease in the expres-
sion of hypertrophic markers Col X and Runx2, suggesting that
muscle cell-derived factors inhibited pro-inﬂammatory cytokine-
induced chondrocyte hypertrophy [Fig. 1(GeH)].
Muscle cell-derived factors strongly inhibit the induction of multiple
MMPs by inﬂammatory stimuli in hMSC-derived chondrocytes
Matrix metalloproteinases MMP1, MMP8, and MMP13 are
involved in the proteolytic degradation of cartilage matrix protein
Col II, while MMP3 activates MMP1 as well as degrades matrix
proteoglycans33. Both IL-1b and TNFa induced a signiﬁcant and
consistent upregulation of MMP1 [Fig. 2(A)], MMP3 [Fig. 2(B)],
MMP8 [Fig. 2(C)], and MMP13 [Fig. 2(D)] in hMSC-derived chon-
drocytes cultured in the control condition. Strikingly, culturing in
C2C12 muscle cell-conditioned medium essentially abolished the
induction of all these MMPs. Even in the absence of pro-
inﬂammatory cytokines, muscle cell-conditioned medium signiﬁ-
cantly reduced expression of MMP3 and MMP13.
Muscle cell-derived factors promote GAG production and Col II
protein expression in the presence of inﬂammatory stimuli
H&E histological analysis showed that the cells were distributed
uniformly throughout scaffolds [Fig. 3(AeF)]. To determine the
levels of cartilage matrix deposition in the cartilage constructs, we
performed toluidine blue staining [Fig. 3(GeL)], as well as immu-
nocytochemical staining for Col II [Fig. 3(MeR)]. While both tolui-
dine blue staining and Col II staining were diminished with the
addition of pro-inﬂammatory cytokines in cells grown in control
conditioned media, staining remained consistent for all cells
cultured with muscle cell-conditioned media, regardless of in-
ﬂammatory cytokine treatment.
To further assess whether muscle cell-derived factors promoted
cartilage matrix production, we quantiﬁed the amount of sulfated
GAG within these constructs using the DMMB assay32. While there
were no observable differences in GAG [Fig. 4(A)] and DNA
[Fig. 4(B)] content among the samples in the absence of cytokine
treatment, constructs cultured in the presence of muscle cell-
derived factors yielded signiﬁcantly higher levels of GAG and
DNA content, as well as GAG/DNA ratio [Fig. 4(C)] under IL-1b, but
not TNFa treatment as compared to the control. This result suggests
that under the inﬂammatory condition of IL-1b, muscle cell-derived
factors promoted the maintenance of cartilage matrix.
Muscle cell-derived factors promote cell proliferation and inhibit
apoptosis under IL-1b treatment
Because we observed that cells cultured in muscle cell-
conditioned medium showed increased DNA content under IL-1b
treatments, we next investigated whether this increase was due to
increased cell proliferation or decreased cell death. To examine cell
proliferation status, we used immunocytochemistry to quantify the
Fig. 2. Relative expression of matrix degradation markers in differentiated hMSCs at Day 21 after treatment of pro-inﬂammatory cytokines and muscle cell-derived factors as
compared with controls. Matrix degradation markers included MMP1 (A), MMP3 (B), MMP8 (C), and MMP13 (D). Expression was normalized to GAPDH. Data are presented as mean
with 95% conﬁdence intervals (n ¼ 3 independent samples (cell-seeded scaffolds) from one experiment completed using one donor’s cells).
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proliferation [Fig. 5(AeB)]. Muscle cell-conditioned medium did
not enhance cell proliferation under non-inﬂammatory conditions,
which is consistent with the quantiﬁcation of total DNA level. IL-1b
treatment completely abolished Ki67 staining, suggesting a strong
inhibition of cell proliferation. Remarkably, under IL-1b treatment,
muscle cell-derived factors induced a stark increase in the per-
centage of Ki67-positive cells. Unlike IL-1b, TNFa did not cause a
signiﬁcant reduction in cell proliferation as compared to the control
condition. Furthermore, no changes in cell proliferation wereFig. 3. Representative histological evaluation of hMSC-derived chondrocytes within silk scaf
cell-derived factors as compared to controls. H&E staining (AeF). Toluidine blue staining f
(Scale bars: 250 mm).observed for TNFa treatment in the presence of muscle cell-derived
factors.
To assay if the change of cell proliferation was caused by altered
expression of cell cycle regulators, we then assessed the mRNA
expression of cell cycle inhibitors p21 [Fig. 5(C)] and p53 [Fig. 5(D)].
Culturing with muscle cell-conditioned medium did not signiﬁ-
cantly alter the expression of these two markers under the non-
inﬂammatory conditions. On the other hand, both IL-1b and TNFa
induced the expression of p21, while TNFa also signiﬁcantly
induced p53 expression. Signiﬁcantly, culturing with muscle cell-folds after Day 21 of culture in the presence of pro-inﬂammatory cytokines and muscle
or proteoglycans (GeL) and immunocytochemical staining for type II collagen (MeR).
Fig. 4. Biochemical quantiﬁcation of glycosaminoglycan (A) and DNA (B) content, as
well as ratio of GAG/DNA (C), in differentiated hMSCs at Day 21 after treatment of pro-
inﬂammatory cytokines and muscle cell-derived factors as compared with controls.
Data are presented as mean with 95% conﬁdence intervals (n ¼ 6 independent samples
(cell-seeded scaffolds) using one donor’s cells).
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as TNFa-induced p53 expression.
To determine the effect of muscle cell-derived factors on pro-
inﬂammatory cytokine-induced apoptosis, we then examined the
expression of caspase 3 (CASP3), an enzyme activated in apoptotic
cells [Fig. 5(EeF)]. The number of cells positively-stained for active
CASP3 were signiﬁcantly reduced with the addition of muscle cell-
conditioned medium under IL-1b treatment, a ﬁnding that was
further correlated with the reduction of CASP3 mRNA expression
[Fig. 5(G)]. Muscle cell-conditioned medium did not appear to alter
CASP3mRNA or protein expression under TNFa treatment, which is
consistent with the DNA quantiﬁcations. Nonetheless, our data
clearly suggests that muscle cell-derived factors promote cell pro-
liferation and survival under the treatment of IL-1b.Discussion
Catabolic mediators, in particular pro-inﬂammatory cytokines
IL-1b and TNFa, have been demonstrated to inhibit chondrogenesis
and promote chondrocyte hypertrophy and degradation in OA
joints, thus leading to cartilage instability14. This is especially
important for immature engineered tissues composed of progeni-
tor stem cells actively undergoing chondrogenesis as such con-
structs may not have generated enough protective extracellular
matrix (ECM) at the time of construct implantation and conse-
quently, may be especially more susceptible to degradation12,34.
Indeed, the therapeutic viability of engineered cartilage relies on
methods that promote resistance to these catabolic inducers. Here,
we addressed this challenge by investigating the effects of muscle
cell-derived factors on the stability of cartilage constructs under
inﬂammatory conditions.
Our ﬁndings demonstrated that muscle cell-derived factors
inhibited the mRNA expression of MMPs as well as hypertrophic
markers in bioengineered cartilage. Pro-inﬂammatory cytokines IL-
1b and TNFa cause cartilage destruction by inducing the expression
of MMPs, promoting chondrocyte hypertrophy, and reducing the
synthesis of cartilage matrix genes. Although the induction of hy-
pertrophic markers by IL-1b and TNFa were about 2e4 fold, we
believe this is biologically meaningful as OA chondrocytes are
known to exhibit higher levels of hypertrophy35. For all the MMPs
we examined (MMP1, MMP3, MMP8, and MMP13), muscle cell-
derived factors abolished IL-1b- and TNFa-induced expression at
the mRNA level, indicating a strong impairment of the cartilage-
destructive ability of these pro-inﬂammatory cytokines. Further-
more, we found a signiﬁcant inhibition of hypertrophic markers Col
X and Runx2 in constructs cultured with muscle cell-conditioned
medium, suggesting that muscle cell-derived factors inhibited the
terminal differentiation of hMSCs, which is one of the major ob-
stacles for the translational application of hMSC chondrogenesis36.
These results were consistent among all three donors tested (Figs. 1
and 2 for donor #1; Fig. S2 for donors #2 and #3). Although there
were no differences in the mRNA expression of Col II and ACAN in
hMSC-derived chondrocytes cultured with muscle cell-conditioned
medium, the dramatic reduction of MMPs and the inhibition of
chondrocyte hypertrophy could result in the maintenance of pro-
tein expression of cartilage matrix components under inﬂamma-
tory conditions.
Thus, to substantiate our RT-PCR gene expression analyses, we
performed biochemical and histological studies to quantitatively
and qualitatively evaluate the expression of cartilage matrix pro-
teins. Our immunocytochemistry and toluidine blue staining
results showed that cartilage matrix proteins, mainly Col II and
total proteoglycan, produced by constructs exposed to muscle cell-
conditioned mediumwere maintained as compared to non-muscle
cell-conditioned medium under IL-1b or TNFa stimulation. Quan-
tiﬁcation of sulfated GAG content revealed only statistically sig-
niﬁcant differences in GAG levels between muscle-treated samples
and controls in the case of IL-1b stimulation. For TNFa treatments, it
is not clear why there are no quantiﬁable signiﬁcant differences in
GAG content as compared to the proteoglycan histological staining.
Such difference in results may be likely due to the fact that while
the DMMB dye, which was used for GAG quantiﬁcation, only binds
to sulfated proteoglycans, toluidine blue stains both sulfated and
non-sulfated proteoglycans, such as hyaluronan37. Further investi-
gation of individual proteoglycan components may help to under-
stand whether muscle cell-derived factors promote additional
cartilage matrix components in maintaining the stability of hMSC-
derived chondrocytes under inﬂammatory conditions. It should be
noted that TNFa led to a higher level of cartilage destruction as
evidenced by its stronger induction of chondrocyte hypertrophic
Fig. 5. Biochemical quantiﬁcation and relative gene expression analysis of cell proliferation, cell cycle regulation, and apoptosis. Cells were stained via immunocytochemistry for
proliferative marker Ki67 (A) and the percentage of Ki67 þ stained cells were quantiﬁed (B). mRNA expression for markers for cell cycle regulation and inhibition included p21 (C)
and p53 (D). Cells were stained via immunocytochemistry for active caspase 3 (CASP3) (E) And the percentage of positively stained cells were quantiﬁed (F). mRNA expression for
CASP3 was also assessed (G). All mRNA expression was normalized to GAPDH. For immunocytochemistry, sections were counterstained with methyl green. Data are presented as
mean with 95% conﬁdence intervals (n ¼ 4 sections for quantiﬁcation of Ki67 þ cells, n ¼ 3 independent samples (cell-seeded scaffolds) for RT-PCR, and n ¼ 6 sections for
quantiﬁcation of caspase 3 þ cells).
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Consequently, to overcome the inﬂammatory damage induced by
TNFa, a larger amount of muscle cell-derived factors may be
required. Finally, these results are consistent with our prior study
using rat chondrosarcoma (RCS) chondrocytes in 2D cultures,
which showed that muscle cell-secreted factors promoted cartilagematrix protein expression under inﬂammatory cytokine
treatments30,31.
To further explore the mechanisms by which muscle cell-derived
factors regulate chondrocyte stability under inﬂammatory condi
tions, we analyzed cell proliferation and cell death. Muscle cell-
derived factors strongly rescued IL-1b-induced growth arrest, which
R.S. Rainbow et al. / Osteoarthritis and Cartilage 21 (2013) 990e998 997may be mediated in part by downregulating the expression of cell
cycle inhibitor p21. Although p53 mRNA expression was not induced
by IL-1bor inhibitedbymuscle cell-conditionedmedium, it isnot clear
whether the level of p53 activation was altered in these conditions.
Interestingly, TNFa did not change the proliferation level in these cells
as assayed by Ki67 staining; however, it did signiﬁcantly induce p21
and p53 expression. It has been established that these two tran-
scription factors, in addition to their function as cell cycle inhibitors,
also play a signiﬁcant role in cellular aging and senescence38, two
events that are involved in the pathogenesis of OA39. Thus, it possible
that IL-1b and TNFa induce cellular aging and senescence aswell, and
it will be interesting to determine the effect of muscle cell-derived
factors on these pro-inﬂammatory cytokine-induced events.
We also observed that muscle cell-derived factors inhibited IL-
1b-induced CASP3 mRNA expression but did not inhibit TNFa-
induced expression. As noted previously, higher levels of muscle
cell-conditioned medium might be required to overcome TNFa-
induced CASP3 expression, as TNFa typically is a stronger inducer of
apoptosis40,41. Furthermore, it is worth noting that while cytokine-
induced increases in CASP3 mRNA expressionwere observed, there
was no similar trend observed in cytokine-induced protein
expression of active CASP3, a cleaved product of pro-CASP3. Here, it
is not clear whether the enzymatic activity of CASP3 was altered by
IL-1b and TNFa. What our data clearly shows is that muscle cell-
conditioned medium signiﬁcantly inhibited the protein expres-
sion of activated CASP3 with respect to IL-1b treatment. These
ﬁndings parallel the observed increase in DNA content by muscle
cell-derived factors during IL-1b treatment and further propose the
role of muscle in promoting cell survival under the condition of IL-
1b treatment.
Several future studies can stem from the results presented here.
It is important to determine the effective component(s) in the
muscle cell-conditioned medium that are contributing to the
observed prevention of matrix degradation. Recently, muscle has
been recognized as an endocrine organ and is found to secrete
multiplemyokines42. Althoughmuscle lies outside the ﬁbrous tissue
of the joint capsule, it is in the position to inﬂuence cartilage gene
expression locally and systemically, as these myokines can poten-
tially pass through this capsule. In fact, it was reported that synovial
ﬁbroblasts of RA joints could even spread from one joint to
another43. However, we are not clear which myokines regulate the
response of chondrocytes toward inﬂammatory stimuli. Identiﬁca-
tion of relevant myokines will provide further insight into cartilage
development and may help develop a new platform for tissue en-
gineering technologies, as key factors could be coupled with the
biomaterial scaffolding or can be expressed locally in situ. Addi-
tionally, in our study, we did not selectively isolate muscle cells at a
speciﬁc stage of myogenesis (myoblast, myocyte, or myotube) but
used amixed population of muscle cells. As each stage has a variable
gene expression proﬁle44, further studies are warranted to identify
what secreted factors in which speciﬁc stage contribute to the sta-
bility of hMSC-derived chondrocytes. Furthermore, this work in-
volves the use of factors derived from the rodent C2C12 muscle cell
line. For therapeutic relevance, additional study is recommended
using primary humanmuscle cells to ensure that the effect observed
is indeed due to myokines and not to non-muscle speciﬁc murine
factors. Finally, it is still unclear howmuscle cell-derived factorsmay
alter the activity of IL-1b and TNFa. The complete inhibition of
chondrocyte hypertrophy as well as the expression of all of the
MMPs bymuscle cell-derived factors is particularly striking. The fact
that the mRNA levels of collagen II and ACAN were unaffected
suggests that this effect is very speciﬁc to the degradation cascade
elicited by these pro-inﬂammatory cytokines. As NF-kB activation is
the key event that mediates the subsequent upregulation of MMPs
by both IL-1b and TNFa during chondrogenic inhibition34,45, itwould be interesting to further explore the effect of muscle cell-
derived factors on NF-kB activation.
In summary, our ﬁndings reveal an important role of muscle in
regulating cartilage homeostasis and offer a mechanism to promote
stability and resistance in engineered cartilage to pro-inﬂammatory
cytokines. We hope this study will lead to a deeper understanding
of the control of cartilage development, which may eventually be
harnessed to improve tissue engineering strategies.
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